Evidence for a putative relationship between type 2 diabetes and neoplasia with particular reference to breast cancer: Role of hormones, growth factors and specific receptors

Current Drug Targets: Immune, Endocrine and Metabolic Disorders

Volumn 4, Issue 1, 2004, Pages 59-66

  Guastamacchia, E ^a   Resta, F ^a   Triggiani, V ^a   Liso, A ^b   Licchelli, B ^a   Ghiyasaldin, S ^a   Sabba C ^a   Tafaro, E ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Breast cancer; Diabetes; Estrogen receptor; Growth factors; Hormones; Progesteron receptor

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANDROGEN; ESTROGEN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HORMONE; HORMONE RECEPTOR; INSULIN; METFORMIN; SOMATOMEDIN C; GROWTH PROMOTOR; INSULIN RECEPTOR; SEX HORMONE;

BLOOD LEVEL; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CHRONIC DISEASE; DIET; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENDOMETRIUM CANCER; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; HORMONE ACTION; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; HYPERTENSION; HYPERURICEMIA; INCIDENCE; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PROSTATE CANCER; PROTEIN FUNCTION; REVIEW; ANIMAL; BREAST TUMOR; METABOLISM; RISK FACTOR;

ANIMALS; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; GONADAL STEROID HORMONES; GROWTH SUBSTANCES; HUMANS; RECEPTOR, INSULIN; RISK FACTORS;

EID: 2142763871     PISSN: 15680088     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568008043339965     Document Type: Review

References (42)

1. Kessler, I.I. (1970) J. Nation. Cancer Inst., 44(3), 673-686.
2. Kessler, I.I. (1971) J. Chron. Dis., 23(8), 579-600.
3. Armstrong, B.; Lea, A.J.; Adelstein, A.M.; Donovan, J.W.; White, G.C. and Ruttle, S. (1976) Br. J. Prev. Soc. Med., 30(3), 151-157.
4. Ragozzino, M.; Melton 3°, L.J.; Chu, C.P. and Palumbo, P.J. (1982) J. Chron. Dis., 35(1), 13-19.
5. Green, A. and Hougaard, P. (1984) Diabetologia, 26(3), 190-194.
6. O'Mara, B.A.; Byers, T. and Schoenfeld, E. (1985) J. Chron. Dis., 38(15), 435-441.
7. Davey Smith, G.; Egger, M.; Shipley, M.J. and Marmot, M.G. (1992) Am. J. Epidemiol., 136(11), 1110-1114.
8. La Vecchia, C.; Negri, E.; Franceschi, S.; D'Avanzo, B. and Boyle, P. (1994) Br. J. Cancer, 70(5), 950-953.
9. Shaw, J.E.; Hodge, A.M.; de Courten, M.; Chitson, P. and Zimmet, P.Z. (1999) Diabetologia, 42(9), 1050-1054.
10. Ish-Shalom, D.; Christoffersen, C.T.; Vorwerk, P.; Sacerdoti-Sierra, N.; Shymko, R.M.; Naor, D. and De Meyts, P. (1997) Diabetologia, 40(Suppl. 2), S25-S31.
11. La Vecchia, C.; Negri, E.; Decarli, A. and Franceschi, S. (1997) Int. J. Cancer, 73(2), 204-207.
12. Ross, C.M. (1999) J. Natl. Cancer Inst., 91(15), 1334-1341.
13. Wynder, E.L.; Mabuchi, K. and Whitmore, W.F. Jr. (1974) J. Natl. Cancer Inst., 53(9), 1619-1634.
14. McCredie, M. and Stewart, J.H. (1992) Cancer Causes Control, 3(4), 323-331.
15. Schlehofer, B.; Pommer, W. and Mellemgaard, A. (1996) Int. J. Cancer, 66(6), 723-726.
16. Mellemgaard, A.; Engholm, G.; Niwa, S.; Mehl, E.S.; McLaughlin, J.K. and Olsen J.H. (1994) Int. J. Epidemiol., 23(5), 923-930.
17. Adami, H.O.; McLaughlin, J. and Ekbom, A. (1991) Cancer Causes Control, 2(5), 307-314.
18. Wideroff, L.; Gridley, G. and Mellemkjaer, L. (1997) J. Natl. Cancer Inst., 89(18), 1360-1365.
19. McLaughlin, J.K. (1984) Adv. Modern Environm. Toxicol., 7(3), 227-244.
20. Hajdu, S.I. and Thomas, A.G. (1967) J. Urol., 97(6), 978-982.
21. Grosse, H. (1990) Z. Urol. Nephrol., 83(10), 533-537.
22. Lindblad, P.; Chow, W.H.; Chan, J.; Bergström, A.; Wolk, A.; Gridley, G.; McLaughlin, J.K.; Nyrén, O. and Adami, H.O. (1999) Diabetologia, 42(1), 107-112.
23. Weiderpass, E.; Gridley, G.; Persson, I.; Nyren, O.; Ekbom, A. and Adami, H.O. (1997) Int. J. Cancer, 71(3), 360-363.
24. Parazzini, F.; La Vecchia, C.; Negri, E.; Riboldi, G.L.; Surace, M.; Benzi, G.; Maina, A. and Chiaffarino, F. (1999) Int. J. Cancer, 81(4), 539-542.
25. Weiderpass, E.; Persson, I.; Adami, H.O.; Magnusson, C.; Lindgren, A. and Baron, J.A. (2000) Cancer Causes Control, 11(2), 185-192.
26. Jernstrom, H. and Barret-Connor, E. (1999) J. Women Health Gend. Based Med., 8(10), 1265-1272.
27. La Vecchia, C.; Negri, E.; Franceschi, S.; Talamini, R.; Bruzzi, P.; Palli, D. and Decarli, A. (1997) Br. J. Cancer, 75(3), 441-444.
28. Sellers, T.A.; Anderson, K.E.; Olson, J. and Folsom, A.R. (1998) Epidemiology, 9(1), 102-105.
29. Will, J.C.; Vinicor, F. and Calle, E.E. (1999) Epidemiology, 10(3), 313-318.
30. Poma, A.; Zenonos, A.; Guerrisi, L.; Calefato, V. and Buromzo, G.V. (1982) Giorn. Ital. Diabetol., 2(4), 325-332.
31. Silverman, D.T.; Schiffman, M.; Everhart, J.; Goldstein, A.; Lillemoe, K.D.; Swanson, G.M.; Schwartz, A.G.; Brown, L.M.; Greenberg, R.S.; Schoenberg, J.B.; Pottern, L.M.; Hoover, R.N. and Fraumeni, J.F. Jr. (1999) Brit. J. Cancer, 80(11), 1830-1837.
32. Gullo, L. (1999) Ann. Oncol., 10(Suppl. 4), 79-81.
33. Shymko, R.M.; Dumont, E.; De Meyts, P. and Dumont, J.E. (1999) Biochem. J., 339(3), 675-683.
34. Kaaks, R. (1996) Cancer Causes Control, 7(6), 605-625.
35. Bruning, P.F.; Bonfrer, J.M.; van Noord, P.A.; Hart, A.A., de Jong-Bakker, M. and Nooijen, W.J. (1992) Int. J. Cancer, 52(4), 511-516.
36. Kazer, R.R. (1995). Int. J. Cancer, 62(4), 403-406.
37. Talamini, R.; Franceschi, S.; Favero, A.; Negri, E.; Parazzini, F. and La Vecchia, C. (1997) Br. J. Cancer, 75(11), 1699-1703.
38. Brunetti, P. (1997) in Medicina Interna, Società Editrice Universo, Roma, pp. 1752-1755.
39. Lee, A.V.; Weng, C.N.; Jackson, J.G. and Yee, D. (1997) J. Endocrinol., 152(1), 39-47.
40. Giovannucci, E. (1999) Horm. Res., 51(Suppl. 3), 34-41.
41. Shire, N.K. (1998) Texas Medical Center News, 20, 10.
42. Dandona, P.; Thusu, K.; Cook, S.; Snyder, B.; Makowski, J.; Armstrong, D. and Nicotera, T. (1996) Lancet, 347(8999), 444-445.